Skip to content

Impact of intradermal needle therapy on rapid recovery after laparoscopic gastrointestinal tumor surgery

Impact of intradermal needle therapy on rapid recovery after laparoscopic gastrointestinal tumor surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082555
Enrollment
Unknown
Registered
2024-04-01
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal tumor

Interventions

Experimental group:Conventional treatment + Intradermal Needle Therapy
Control group:Conventional treatment+Sham Intradermal Needle Therapy

Sponsors

Shaanxi Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age above 18 years; 2.Laparoscopic gastrointestinal surgery has been performed; 3.Abdominal surgery has been performed for the first time; 4.American Society of Anesthesiologists (ASA) grade I–III; 5.Willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1Combined organ resection; 2Conversion to open surgery; 3Intestinal stoma or gastrostomy; 4Associated with severe heart, lung, liver, and kidney dysfunction; 5Patients with mental disorders; 6Need for ICU treatment after surgery; 7Development of severe complications after surgery; 8Secondary surgery after surgery.

Design outcomes

Primary

MeasureTime frame
Time of first exhaust. Time of first defecation.;

Secondary

MeasureTime frame
Postoperative pain VAS score;Postoperative nausea and vomiting VAS score;VAS score for abdominal distension;Recovery time of bowel sounds;Time of water intake through the mouth;

Countries

China

Contacts

Public ContactWang Jianhua

Shaanxi Provincial People's Hospital

wangjianhuaman@163.com+86 134 6862 3811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026